ORIC Hires Genentech’s Hanna as CEO, Adds New Chief Business Officer

Xconomy San Francisco — 

South San Francisco, CA-based ORIC Pharmaceuticals has named Ashraf Hanna its CEO, replacing Rich Heyman, who helped ORIC raise a $53 million Series B in December while filling the role on an interim basis. Hanna was previously a commercial and medical affairs executive at Genentech, as well as the CFO of the Genentech Foundation. Heyman is remaining on the company’s board. ORIC also hired Darcy Mootz, the former vice president of corporate development at Achaogen, as its chief business officer.